Brigham and Women's Hospital, Department of Neurology

Boston, Massachusetts 02215

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer's Disease, Alzheimer's Disease Dementia, Amyotrophic Lateral Sclerosis, At Risk for Cognitive Decline, Dementia, Mild, LGI1 Autoimmune Encephalitis, Lou Gehrig's Disease, Mild Cognitive Impairment, Mild Cognitive Impairment Due to Alzheimer's Disease, NMDAR Autoimmune Encephalitis, Subjective Cognitive Decline

Studies at this site

• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• The Brain Health Champion Study — Running, not enrolling
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• Clinical Trial of High Dose CoQ10 in ALS — Completed
• Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early